Xiaohong Zhou, M.D., O.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diffusion Magnetic Resonance Imaging | 16 | 2023 | 2782 | 2.840 |
Why?
|
| Echo-Planar Imaging | 7 | 2024 | 657 | 2.300 |
Why?
|
| Calculi | 3 | 2021 | 48 | 1.680 |
Why?
|
| Prostate | 2 | 2023 | 1791 | 0.950 |
Why?
|
| Adenoviridae Infections | 4 | 2016 | 93 | 0.840 |
Why?
|
| Aortic Valve | 2 | 2021 | 1950 | 0.750 |
Why?
|
| Adenoviruses, Human | 5 | 2015 | 255 | 0.740 |
Why?
|
| Keratitis | 5 | 2016 | 239 | 0.730 |
Why?
|
| Algorithms | 5 | 2024 | 13959 | 0.710 |
Why?
|
| Leukemic Infiltration | 1 | 2020 | 47 | 0.700 |
Why?
|
| Phantoms, Imaging | 8 | 2023 | 2509 | 0.690 |
Why?
|
| Arthroplasty, Replacement | 1 | 2023 | 310 | 0.690 |
Why?
|
| Acceleration | 1 | 2020 | 189 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2024 | 36285 | 0.660 |
Why?
|
| Artifacts | 4 | 2023 | 1897 | 0.650 |
Why?
|
| Adenovirus Infections, Human | 4 | 2015 | 73 | 0.630 |
Why?
|
| Substantia Nigra | 1 | 2019 | 350 | 0.560 |
Why?
|
| Dextrans | 1 | 2018 | 573 | 0.540 |
Why?
|
| Keratoconjunctivitis | 3 | 2015 | 40 | 0.530 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2024 | 4048 | 0.520 |
Why?
|
| Adenoviridae | 3 | 2016 | 1084 | 0.510 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 8981 | 0.510 |
Why?
|
| Image Enhancement | 2 | 2023 | 2880 | 0.490 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2018 | 277 | 0.480 |
Why?
|
| Cerium | 2 | 2011 | 7 | 0.480 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 800 | 0.470 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2018 | 574 | 0.440 |
Why?
|
| Retinal Ganglion Cells | 3 | 2009 | 806 | 0.440 |
Why?
|
| Brain | 10 | 2024 | 26951 | 0.430 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2023 | 3339 | 0.410 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 581 | 0.400 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 2387 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2024 | 8946 | 0.390 |
Why?
|
| Interleukin-18 | 4 | 2009 | 250 | 0.370 |
Why?
|
| Receptors, LDL | 2 | 2011 | 485 | 0.370 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1422 | 0.360 |
Why?
|
| Bone Marrow | 2 | 2022 | 2909 | 0.360 |
Why?
|
| Retinal Neovascularization | 2 | 2011 | 273 | 0.360 |
Why?
|
| Glioma | 2 | 2021 | 3418 | 0.310 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 2276 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 1 | 2021 | 2002 | 0.310 |
Why?
|
| ROC Curve | 3 | 2021 | 3563 | 0.310 |
Why?
|
| Eye Proteins | 3 | 2009 | 633 | 0.310 |
Why?
|
| Glaucoma | 2 | 2009 | 1182 | 0.300 |
Why?
|
| Serpins | 2 | 2009 | 247 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 3599 | 0.290 |
Why?
|
| Motion | 3 | 2023 | 779 | 0.290 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 562 | 0.280 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1852 | 0.250 |
Why?
|
| Estradiol | 3 | 2007 | 1933 | 0.240 |
Why?
|
| Eye Infections, Viral | 2 | 2016 | 60 | 0.240 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2862 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5246 | 0.240 |
Why?
|
| Retinal Degeneration | 4 | 2011 | 412 | 0.230 |
Why?
|
| Thioredoxins | 4 | 2010 | 201 | 0.230 |
Why?
|
| Humans | 42 | 2024 | 758381 | 0.220 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6313 | 0.220 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2011 | 203 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2009 | 955 | 0.210 |
Why?
|
| Cornea | 5 | 2016 | 1326 | 0.200 |
Why?
|
| Mice, Inbred DBA | 3 | 2009 | 622 | 0.200 |
Why?
|
| Research Subjects | 1 | 2023 | 249 | 0.190 |
Why?
|
| Virus Internalization | 2 | 2016 | 494 | 0.190 |
Why?
|
| Viral Tropism | 3 | 2015 | 102 | 0.170 |
Why?
|
| Permeability | 2 | 2019 | 718 | 0.170 |
Why?
|
| Radio Waves | 1 | 2021 | 250 | 0.170 |
Why?
|
| Corneal Stroma | 3 | 2016 | 171 | 0.170 |
Why?
|
| Capsid Proteins | 2 | 2015 | 467 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1793 | 0.160 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 88 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13245 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 22006 | 0.160 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2005 | 734 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 2239 | 0.150 |
Why?
|
| Oscillometry | 1 | 2018 | 145 | 0.150 |
Why?
|
| Brain Mapping | 2 | 2024 | 6570 | 0.150 |
Why?
|
| Disease Models, Animal | 10 | 2016 | 18125 | 0.150 |
Why?
|
| Thiocyanates | 2 | 2008 | 70 | 0.150 |
Why?
|
| Normal Distribution | 1 | 2018 | 272 | 0.150 |
Why?
|
| Porosity | 1 | 2018 | 349 | 0.150 |
Why?
|
| Gels | 1 | 2018 | 419 | 0.140 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2016 | 234 | 0.140 |
Why?
|
| Head | 1 | 2023 | 921 | 0.140 |
Why?
|
| Diffusion | 1 | 2018 | 813 | 0.140 |
Why?
|
| Male | 15 | 2024 | 358742 | 0.140 |
Why?
|
| src-Family Kinases | 2 | 2016 | 535 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2021 | 54136 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2022 | 1436 | 0.130 |
Why?
|
| Mice | 18 | 2018 | 81107 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2016 | 261 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2021 | 1166 | 0.120 |
Why?
|
| Actigraphy | 1 | 2018 | 518 | 0.120 |
Why?
|
| Retina | 5 | 2010 | 2637 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2016 | 346 | 0.120 |
Why?
|
| Nerve Fibers | 2 | 2009 | 708 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2011 | 2905 | 0.120 |
Why?
|
| Breast | 1 | 2023 | 1963 | 0.110 |
Why?
|
| Muscles | 1 | 2018 | 1579 | 0.110 |
Why?
|
| Atrophy | 1 | 2018 | 1627 | 0.110 |
Why?
|
| Mice, Knockout | 6 | 2016 | 14354 | 0.110 |
Why?
|
| Animals | 20 | 2018 | 167777 | 0.110 |
Why?
|
| Tuberous Sclerosis | 1 | 2021 | 1030 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1256 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 1245 | 0.110 |
Why?
|
| Genome, Viral | 2 | 2015 | 658 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 4567 | 0.100 |
Why?
|
| Reaction Time | 1 | 2018 | 2075 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2013 | 256 | 0.100 |
Why?
|
| Adenovirus E3 Proteins | 1 | 2011 | 7 | 0.100 |
Why?
|
| Female | 16 | 2024 | 390316 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2023 | 20052 | 0.100 |
Why?
|
| Apoptosis | 7 | 2011 | 9468 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3801 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2024 | 6201 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 1526 | 0.090 |
Why?
|
| Intraocular Pressure | 2 | 2007 | 1288 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2009 | 550 | 0.090 |
Why?
|
| Adult | 6 | 2024 | 219916 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2007 | 294 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 22030 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1541 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2007 | 2472 | 0.080 |
Why?
|
| Corneal Diseases | 1 | 2015 | 536 | 0.080 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2008 | 32 | 0.080 |
Why?
|
| Intravitreal Injections | 1 | 2011 | 384 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2015 | 5864 | 0.080 |
Why?
|
| Epitopes | 1 | 2015 | 2502 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 609 | 0.080 |
Why?
|
| DNA, Viral | 2 | 2013 | 2194 | 0.080 |
Why?
|
| Echocardiography | 1 | 2021 | 4962 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2008 | 728 | 0.080 |
Why?
|
| Cell Count | 2 | 2010 | 1835 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2018 | 2685 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4901 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2011 | 5031 | 0.070 |
Why?
|
| Cognition | 2 | 2023 | 6955 | 0.070 |
Why?
|
| Digoxigenin | 1 | 2007 | 26 | 0.070 |
Why?
|
| Capsid | 1 | 2010 | 434 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2013 | 651 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 129 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5629 | 0.070 |
Why?
|
| Eye | 1 | 2011 | 710 | 0.070 |
Why?
|
| Estrogen Antagonists | 1 | 2007 | 151 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 396 | 0.070 |
Why?
|
| Drug Implants | 1 | 2007 | 230 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2129 | 0.070 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 236 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2010 | 781 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1335 | 0.060 |
Why?
|
| Survival Rate | 1 | 2020 | 12721 | 0.060 |
Why?
|
| Optic Nerve | 1 | 2009 | 567 | 0.060 |
Why?
|
| Electroretinography | 4 | 2011 | 517 | 0.060 |
Why?
|
| Exercise | 1 | 2022 | 5788 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2007 | 963 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 151 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2016 | 2723 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22031 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2007 | 610 | 0.060 |
Why?
|
| Ciliary Body | 1 | 2005 | 166 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 490 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2010 | 1185 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4711 | 0.060 |
Why?
|
| Iris | 1 | 2005 | 231 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3211 | 0.060 |
Why?
|
| Cell Survival | 2 | 2011 | 5781 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2018 | 5070 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15225 | 0.060 |
Why?
|
| Middle Aged | 5 | 2022 | 219560 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1667 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2011 | 1001 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 899 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3046 | 0.050 |
Why?
|
| Light | 2 | 2005 | 1345 | 0.050 |
Why?
|
| Cochlea | 1 | 2008 | 844 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 585 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2011 | 1267 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 11070 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3758 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2007 | 8297 | 0.050 |
Why?
|
| Macrophages | 1 | 2016 | 5737 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9696 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3593 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8611 | 0.050 |
Why?
|
| Aged | 4 | 2023 | 168217 | 0.050 |
Why?
|
| Transfection | 1 | 2009 | 5779 | 0.050 |
Why?
|
| Proteins | 4 | 2011 | 6026 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2011 | 1940 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2009 | 2642 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29558 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 881 | 0.040 |
Why?
|
| Perfusion | 1 | 2023 | 1374 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 29915 | 0.040 |
Why?
|
| Sulfoxides | 2 | 2008 | 46 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11336 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2011 | 23341 | 0.040 |
Why?
|
| Isothiocyanates | 2 | 2008 | 48 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2895 | 0.040 |
Why?
|
| Antioxidants | 1 | 2006 | 1662 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2007 | 4114 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25953 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4342 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 58808 | 0.040 |
Why?
|
| Gene Expression | 2 | 2010 | 7583 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1969 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 94 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2016 | 105 | 0.030 |
Why?
|
| Cell Line | 3 | 2015 | 15594 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 87888 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21017 | 0.030 |
Why?
|
| Tetrazolium Salts | 2 | 2006 | 92 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 614 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2008 | 374 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2322 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3100 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1751 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 3997 | 0.030 |
Why?
|
| Vision, Ocular | 2 | 2010 | 454 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 12076 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1788 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2858 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2015 | 348 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 695 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 1721 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 513 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2006 | 728 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4485 | 0.020 |
Why?
|
| Acute Disease | 1 | 2022 | 7225 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4406 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9518 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 11894 | 0.020 |
Why?
|
| Aging | 2 | 2008 | 8651 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 66 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3816 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 482 | 0.020 |
Why?
|
| Insulin | 1 | 2004 | 6578 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2010 | 649 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18357 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2176 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1492 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8554 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2774 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 10171 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 604 | 0.020 |
Why?
|
| Thiazoles | 2 | 2006 | 1511 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4745 | 0.020 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2007 | 44 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2008 | 249 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2443 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 2753 | 0.020 |
Why?
|
| Nerve Net | 1 | 2018 | 2263 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 913 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 597 | 0.020 |
Why?
|
| Arrestin | 1 | 2005 | 30 | 0.020 |
Why?
|
| Transducin | 1 | 2005 | 42 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2013 | 1803 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 209 | 0.020 |
Why?
|
| Oxidants | 1 | 2006 | 169 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3966 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 173 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10146 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 3709 | 0.020 |
Why?
|
| Recoverin | 1 | 2004 | 11 | 0.010 |
Why?
|
| Cholesterol | 1 | 2013 | 2901 | 0.010 |
Why?
|
| Hippocalcin | 1 | 2004 | 7 | 0.010 |
Why?
|
| Cell Separation | 1 | 2010 | 1720 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 748 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 148 | 0.010 |
Why?
|
| Flavonoids | 1 | 2007 | 443 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 237 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 1125 | 0.010 |
Why?
|
| Virus Replication | 1 | 2011 | 2430 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1972 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4087 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 361 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5410 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2011 | 2836 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 876 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6233 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 564 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13468 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 2673 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1743 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 560 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13447 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2470 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 580 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17617 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 833 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 1963 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 742 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2006 | 18942 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1066 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3774 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3480 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 64379 | 0.010 |
Why?
|
| Child | 1 | 2021 | 79813 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26182 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8144 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80170 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12760 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10747 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9312 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9461 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 23681 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9418 | 0.000 |
Why?
|